Accordingly to this https://www.fnarena.com/index.php/2021/07/14/patent-dispute-shrouds-nearmaps-us-expansion/
"Commenting on the legal dispute, Jefferies notes Nearmap has deep pockets to defend its position. Given that patent infringement litigation has been used tactically across other sectors, notably healthcare, Jefferies suspects the case with Nearmap will more than likely resolve in the company's favour.
- Forums
- ASX - By Stock
- NEA
- Ann: FY21 preliminary results, exceeds recently upgraded guidance
Ann: FY21 preliminary results, exceeds recently upgraded guidance, page-81
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)